What's breaking now, across thousands of outlets.
Armed with a $300 million financing and two GLP-1 and amylin-targeting medicines, Corxel is set to become the latest weight loss-focused company to join the public markets.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
This is one outlet's version. Read the fullest account.
Officials on opposite sides of the African continent are trying to determine how a woman diagnosed with Ebola in Nigeria's capital last week contracted the deadly virus without having visited the…
A six-month partnership between the state, the White House and tech vendors will bolster rural hospitals' defenses while evaluating technologies for nationwide deployment.
Cameroon, Benin and Madagascar tighten Ebola checks after Nigeria's first case on 20 October 2026, and none has recorded a case.
The Ghana AIDS Commission is introducing measures to make HIV testing more accessible and confidential for young people as part of efforts to reduce stigma and encourage early testing.
(MedPage Today) -- A next-generation KRAS G12C inhibitor significantly improved survival outcomes versus first-generation drugs for previously treated advanced or metastatic non-small cell lung…
